We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-14.21%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$89.1B
AUM Growth
+$88.9B
Cap. Flow
-$3.22B
Cap. Flow %
-3.61%
Top 10 Hldgs %
11.59%
Holding
2,672
New
86
Increased
706
Reduced
853
Closed
108

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$504M
2
AAPL icon
Apple
AAPL
+$433M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$248M
4
VTRS icon
Viatris
VTRS
+$241M
5
AMZN icon
Amazon
AMZN
+$210M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.43%
3 Financials 13.5%
4 Industrials 10.21%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UGI icon
1176
UGI
UGI
$7.95B
$2.62M ﹤0.01%
67,771
-8,310
-11% -$322K
DOX icon
1177
Amdocs
DOX
$5.71B
$2.62M ﹤0.01%
31,400
CNM icon
1178
Core & Main
CNM
$8.11B
$2.61M ﹤0.01%
117,071
-11,647
-9% -$270K
RMD icon
1179
ResMed
RMD
$29.4B
$2.61M ﹤0.01%
12,433
+7,116
+134% +$1.51M
NCNO icon
1180
nCino
NCNO
$1.98B
$2.59M ﹤0.01%
83,913
-40,034
-32% -$1.41M
RITM icon
1181
Rithm Capital
RITM
$5.18B
$2.58M ﹤0.01%
277,445
TDOC icon
1182
Teladoc Health
TDOC
$1.6B
$2.57M ﹤0.01%
77,531
+34,556
+80% +$1.47M
SKY icon
1183
Champion Homes
SKY
$4.5B
$2.56M ﹤0.01%
54,030
+545
+1% +$28.1K
WEX icon
1184
WEX
WEX
$6.1B
$2.56M ﹤0.01%
16,471
-482
-3% -$78.9K
LHX icon
1185
L3Harris
LHX
$56.7B
$2.55M ﹤0.01%
10,549
-2,919
-22% -$705K
IVZ icon
1186
Invesco
IVZ
$13.2B
$2.54M ﹤0.01%
157,322
-3,686
-2% -$69.7K
SHLS icon
1187
Shoals Technologies Group
SHLS
$1.52B
$2.53M ﹤0.01%
153,808
+149,477
+3,451% +$2.21M
FLYW icon
1188
Flywire
FLYW
$2B
$2.52M ﹤0.01%
143,193
+77,459
+118% +$1.8M
TARS icon
1189
Tarsus Pharmaceuticals
TARS
$2.66B
$2.52M ﹤0.01%
+172,908
New +$2.6M
IMKTA icon
1190
Ingles Markets
IMKTA
$1.67B
$2.5M ﹤0.01%
28,851
-6,900
-19% -$628K
GLW icon
1191
Corning
GLW
$120B
$2.5M ﹤0.01%
79,386
-21,555
-21% -$743K
SANM icon
1192
Sanmina
SANM
$10.8B
$2.49M ﹤0.01%
61,251
MRNA icon
1193
Moderna
MRNA
$22.3B
$2.49M ﹤0.01%
17,448
-378,931
-96% -$54.2M
MYGN icon
1194
Myriad Genetics
MYGN
$527M
$2.48M ﹤0.01%
136,620
SFM icon
1195
Sprouts Farmers Market
SFM
$7.19B
$2.48M ﹤0.01%
97,955
+995
+1% +$27.6K
EVOP
1196
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$2.48M ﹤0.01%
105,219
-1,324
-1% -$30.2K
DPZ icon
1197
Domino's
DPZ
$11.5B
$2.47M ﹤0.01%
5,817
-528
-8% -$195K
LAMR icon
1198
Lamar Advertising Co
LAMR
$16.5B
$2.47M ﹤0.01%
28,098
+2,053
+8% +$208K
ELAT
1199
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
$2.47M ﹤0.01%
77,293
ASB icon
1200
Associated Banc-Corp
ASB
$5.8B
$2.47M ﹤0.01%
135,211
-6,579
-5% -$133K

Similar funds

Macquarie Group's Q2 2022 Portfolio in Review

As of Q2 2022, Macquarie Group held 2,672 positions worth $89.1B, up 67,641% from $131M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group withdrew a net $3.22B in Q2 2022, closing 108 positions and reducing 853 holdings. Its most notable exit was Healthcare Realty, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Petco worth $56.3M.

  • Macquarie Group's largest Q2 2022 buy was Petco: 3,818,489 shares worth $56.3M.
  • Macquarie Group added most to Hologic in Q2 2022, an estimated $324M increase.
  • Macquarie Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $504M.
  • Macquarie Group fully exited Healthcare Realty in Q2 2022, selling an estimated $10.8M.
  • Macquarie Group's ten largest holdings make up 12% of its $89.1B portfolio in Q2 2022.
  • Macquarie Group opened 86 new positions and closed 108 in Q2 2022.
  • Macquarie Group's portfolio value rose 67,641% quarter-over-quarter to $89.1B.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.